Hanak Brian W, Haussen Diogo C, Ambekar Sudheer, Ferreira Manuel, Ghodke Basavaraj V, Peterson Eric C
Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
J Neurointerv Surg. 2016 Oct;8(10):1084-94. doi: 10.1136/neurintsurg-2015-011980. Epub 2015 Oct 16.
Hemangiopericytomas (HPCs) are rare dural-based neoplasms. Preoperative embolization of these notoriously hypervascular tumors can be challenging as they often receive their dominant blood supply from pial feeders arising from the internal carotid artery (ICA) or vertebrobasilar (VB) circulation. This study reviews our historical experience with HPC embolization and introduces the transtumoral technique for backfilling pial tumor vasculature by delivering Onyx-18 through diminutive external carotid artery (ECA) feeders.
A retrospective review of all preoperative HPC embolizations performed at Anonymous University #1 (September 2002-November 2014) and Anonymous University #2 (January 2014-November 2014) is presented.
Fifteen patients with pathologically confirmed HPC underwent 17 embolizations. More extensive devascularization percentages were achieved for HPCs with primarily ECA blood supply (76.4±10.7%; n=6) than with HPCs supplied via the ICA/VB circulation (57.9±26.9%; n=8; p=0.046). There was a trend towards greater devascularization of ICA/VB-dominant HPCs embolized with Onyx (70.0±34.6%; n=4) versus polyvinyl alcohol particles (33.3±15.3%; n=3). The extent of angiographic devascularization negatively correlated with intraoperative blood loss (rho=-0.71; p=0.005). There were no embolization-related complications.
The extent of preoperative embolization of HPCs correlates with decreased intraoperative blood loss. However, HPCs with an ICA/VB-dominant blood supply remain challenging embolization targets, demonstrating reduced devascularization percentages compared with ECA-dominant counterparts. The authors favor the use of Onyx for ICA/VB-dominant HPCs, noting a trend towards an improved devascularization rate.
血管外皮细胞瘤(HPC)是一种罕见的起源于硬脑膜的肿瘤。这些肿瘤血管极其丰富,术前栓塞具有挑战性,因为它们的主要血供通常来自颈内动脉(ICA)或椎基底动脉(VB)循环发出的软膜供血支。本研究回顾了我们在HPC栓塞方面的既往经验,并介绍了通过微小的颈外动脉(ECA)供血支注入Onyx - 18来回填软膜肿瘤血管的经瘤技术。
对在匿名大学1号(2002年9月 - 2014年11月)和匿名大学2号(2014年1月 - 2014年11月)进行的所有术前HPC栓塞进行回顾性研究。
15例经病理证实的HPC患者接受了17次栓塞。主要由ECA供血的HPC实现的血管减少百分比(76.4±10.7%;n = 6)高于通过ICA/VB循环供血的HPC(57.9±26.9%;n = 8;p = 0.046)。与使用聚乙烯醇颗粒栓塞的以ICA/VB为主的HPC(33.3±15.3%;n = 3)相比,使用Onyx栓塞的以ICA/VB为主的HPC有更大程度血管减少的趋势(70.0±34.6%;n = 4)。血管造影显示的血管减少程度与术中失血量呈负相关(rho = -0.71;p = 0.005)。没有栓塞相关并发症。
HPC术前栓塞程度与术中失血量减少相关。然而,以ICA/VB为主供血的HPC仍是具有挑战性的栓塞靶点,与以ECA为主供血的HPC相比,其血管减少百分比更低。作者倾向于对以ICA/VB为主的HPC使用Onyx,注意到血管减少率有改善的趋势。